See more : iShares U.S. Thematic Rotation Active ETF (THRO) Income Statement Analysis – Financial Results
Complete financial analysis of Charles & Colvard, Ltd. (CTHR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Charles & Colvard, Ltd., a leading company in the Luxury Goods industry within the Consumer Cyclical sector.
You may be interested
- Okeanis Eco Tankers Corp. (OKENF) Income Statement Analysis – Financial Results
- Acast AB (publ) (ACAST.ST) Income Statement Analysis – Financial Results
- Reply S.p.A. (REY.MI) Income Statement Analysis – Financial Results
- Towerstream Corporation (TWER) Income Statement Analysis – Financial Results
- Medigen Biotechnology Corp. (3176.TWO) Income Statement Analysis – Financial Results
Charles & Colvard, Ltd. (CTHR)
About Charles & Colvard, Ltd.
Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. It also markets and distributes lab grown diamonds, and finished jewelry with lab grown diamonds under the Caydia brand. The company sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com, third-party online marketplaces, drop-ship, and other e-commerce outlets. Charles & Colvard, Ltd. was founded in 1995 and is headquartered in Morrisville, North Carolina.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29.95M | 43.09M | 39.24M | 29.19M | 32.24M | 27.03M | 29.17M | 30.77M | 25.64M | 28.49M | 22.41M | 16.03M | 12.69M | 8.31M | 14.73M | 27.82M | 40.71M | 43.54M | 23.92M | 17.24M | 16.51M | 11.51M | 12.80M | 12.30M | 4.00M | 100.00K | 100.00K |
| Cost of Revenue | 25.21M | 22.85M | 20.81M | 21.20M | 17.35M | 15.47M | 20.40M | 20.55M | 18.01M | 14.60M | 9.96M | 6.51M | 4.83M | 3.47M | 5.59M | 7.61M | 10.80M | 14.46M | 8.57M | 6.58M | 6.59M | 5.14M | 5.26M | 5.70M | 2.70M | 0.00 | 0.00 |
| Gross Profit | 4.73M | 20.24M | 18.43M | 7.99M | 14.89M | 11.56M | 8.77M | 10.21M | 7.63M | 13.89M | 12.45M | 9.52M | 7.86M | 4.84M | 9.13M | 20.21M | 29.92M | 29.08M | 15.35M | 10.66M | 9.93M | 6.37M | 7.54M | 6.60M | 1.30M | 100.00K | 100.00K |
| Gross Profit Ratio | 15.81% | 46.98% | 46.96% | 27.37% | 46.19% | 42.77% | 30.06% | 33.20% | 29.75% | 48.75% | 55.56% | 59.39% | 61.96% | 58.22% | 62.02% | 72.65% | 73.48% | 66.78% | 64.17% | 61.86% | 60.11% | 55.34% | 58.90% | 53.66% | 32.50% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 2.07K | 3.71K | 2.85K | 17.80K | 18.07K | 24.90K | 17.01K | 145.72K | 99.89K | 401.50K | 113.62K | 76.65K | 73.23K | 215.78K | 14.08K | 26.70K | 7.26K | 21.98K | 1.44M | 2.70M | 4.00M | 2.10M | 200.00K |
| General & Administrative | 5.02M | 4.95M | 4.44M | 4.86M | 4.64M | 4.69M | 5.54M | 7.38M | 6.79M | 5.48M | 4.76M | 4.67M | 4.53M | 5.70M | 15.92M | 19.81M | 20.41M | 19.74M | 12.29M | 8.54M | 7.37M | 5.33M | 12.72M | 9.40M | 5.70M | 3.30M | 200.00K |
| Selling & Marketing | 13.69M | 12.42M | 8.48M | 9.44M | 7.98M | 7.48M | 7.04M | 12.36M | 9.85M | 9.87M | 7.44M | 3.31M | 1.99M | 1.95M | 7.47M | 14.09M | 16.11M | 15.57M | 9.29M | 6.08M | 4.97M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 18.71M | 17.37M | 12.92M | 14.30M | 12.62M | 12.17M | 12.58M | 19.75M | 16.64M | 15.34M | 12.20M | 7.98M | 6.52M | 7.65M | 15.92M | 19.81M | 20.41M | 19.74M | 12.29M | 8.54M | 7.37M | 5.33M | 12.72M | 9.40M | 5.70M | 3.30M | 200.00K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -13.00 | 0.00 | 20.40M | 0.00 | 0.00 | 0.00 | 0.00 | 94.41K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -450.00 | 119.46K | 569.99K | 700.00K | 200.00K | 0.00 | 0.00 |
| Operating Expenses | 18.71M | 17.37M | 12.92M | 14.30M | 12.63M | 12.17M | 12.59M | 19.76M | 16.66M | 15.37M | 12.22M | 8.22M | 6.62M | 8.05M | 16.03M | 19.88M | 20.49M | 19.95M | 12.31M | 8.57M | 7.38M | 5.47M | 14.73M | 12.80M | 9.90M | 5.40M | 400.00K |
| Cost & Expenses | 43.92M | 40.22M | 33.73M | 35.50M | 29.98M | 27.64M | 32.99M | 40.32M | 34.67M | 29.97M | 22.18M | 14.73M | 11.44M | 11.53M | 21.63M | 27.49M | 31.28M | 34.41M | 20.88M | 15.15M | 13.96M | 10.61M | 19.99M | 18.50M | 12.60M | 5.40M | 400.00K |
| Interest Income | 297.26K | 19.28K | 5.58K | 158.09K | 11.02K | 0.00 | 0.00 | 11.00 | 65.00 | 22.01K | 69.52K | 85.27K | 109.18K | 38.19K | 116.48K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 19.28K | 8.95K | 884.00 | 2.20K | 541.00 | 1.74K | 10.36K | 901.00 | 2.11K | 1.26K | 1.14K | 2.83K | 107.61K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 653.16K | 479.31K | 567.12K | 490.24K | 481.32K | 422.02K | 557.39K | 863.35K | 1.11M | 862.68K | 608.17K | 299.55K | 136.62K | 168.88K | 216.03K | 200.63K | 188.76K | 247.44K | 197.19K | 161.90K | 128.60K | 150.94K | 569.99K | 700.00K | 200.00K | 400.00K | -100.00K |
| EBITDA | -13.03M | 3.35M | 6.23M | -5.67M | 3.14M | -3.85K | -3.38M | -4.32M | -7.94M | -697.70K | 936.01K | 1.68M | 1.46M | -3.36M | -6.57M | 526.07K | 9.62M | 9.38M | 3.24M | 2.09M | 2.55M | 1.05M | -6.62M | -5.50M | -8.40M | -5.30M | -300.00K |
| EBITDA Ratio | -43.50% | 7.83% | 15.50% | -19.42% | 8.55% | -0.69% | -11.18% | -28.23% | -30.91% | -2.10% | 4.08% | 10.51% | 11.73% | -34.88% | -45.39% | 1.89% | 23.62% | 21.54% | 13.53% | 13.09% | 16.23% | 10.17% | -49.31% | -44.72% | -255.00% | -5,800.00% | -300.00% |
| Operating Income | -13.98M | 2.87M | 5.51M | -6.32M | 2.27M | -608.54K | -3.94M | -9.55M | -9.04M | -1.58M | 234.07K | 1.30M | 1.24M | -3.36M | -6.90M | 325.45K | 9.43M | 9.13M | 3.04M | 2.09M | 2.55M | 899.14K | -7.19M | -6.20M | -8.60M | -5.30M | -300.00K |
| Operating Income Ratio | -46.67% | 6.67% | 14.04% | -21.64% | 7.03% | -2.25% | -13.50% | -31.04% | -35.27% | -5.55% | 1.04% | 8.10% | 9.79% | -40.42% | -46.85% | 1.17% | 23.16% | 20.97% | 12.70% | 12.15% | 15.45% | 7.82% | -56.22% | -50.41% | -215.00% | -5,300.00% | -300.00% |
| Total Other Income/Expenses | 297.26K | 19.24K | 970.35K | 155.38K | 8.47K | 182.68K | -1.74K | -10.22K | -836.00 | 19.90K | 68.26K | 84.85K | 80.82K | 38.19K | 116.48K | 491.14K | 741.16K | 503.76K | 138.22K | 112.36K | 199.08K | 325.60K | 114.54K | 1.00M | 1.80M | 500.00K | -100.00K |
| Income Before Tax | -13.68M | 2.89M | 6.48M | -6.16M | 2.27M | -425.87K | -3.94M | -9.56M | -9.05M | -1.56M | 302.33K | 1.38M | 1.32M | -3.32M | -6.78M | 816.58K | 10.17M | 9.63M | 3.18M | 2.21M | 2.75M | 1.22M | -7.08M | -5.20M | -6.70M | -4.90M | -400.00K |
| Income Before Tax Ratio | -45.68% | 6.71% | 16.51% | -21.11% | 7.05% | -1.58% | -13.50% | -31.07% | -35.28% | -5.48% | 1.35% | 8.63% | 10.43% | -39.96% | -46.06% | 2.94% | 24.98% | 22.12% | 13.28% | 12.80% | 16.66% | 10.65% | -55.32% | -42.28% | -167.50% | -4,900.00% | -400.00% |
| Income Tax Expense | 5.90M | 518.53K | -6.33M | 1.73K | -1.44K | 27.61K | 13.48K | 12.82K | 4.05M | -269.29K | -4.15M | -183.95K | -234.28K | 77.71K | -632.67K | 841.01K | 4.07M | 3.76M | 1.56M | 1.16M | -6.66M | -1.22M | 7.08M | 5.20M | 6.70M | 4.90M | 400.00K |
| Net Income | -19.58M | 2.37M | 12.81M | -6.16M | 2.28M | -453.48K | -4.53M | -9.57M | -13.10M | -1.29M | 4.45M | 1.57M | 1.56M | -3.40M | -6.15M | -24.42K | 6.11M | 5.87M | 1.61M | 1.04M | 9.41M | 1.22M | -7.08M | -5.20M | -6.70M | -4.90M | -400.00K |
| Net Income Ratio | -65.39% | 5.51% | 32.65% | -21.11% | 7.06% | -1.68% | -15.52% | -31.11% | -51.08% | -4.53% | 19.85% | 9.78% | 12.27% | -40.89% | -41.77% | -0.09% | 15.00% | 13.49% | 6.74% | 6.05% | 56.97% | 10.65% | -55.32% | -42.28% | -167.50% | -4,900.00% | -400.00% |
| EPS | -0.64 | 0.08 | 0.44 | -0.22 | 0.10 | -0.02 | -0.22 | -0.47 | -0.65 | -0.06 | 0.23 | 0.08 | 0.08 | -0.18 | -0.34 | 0.00 | 0.34 | 0.33 | 0.09 | 0.06 | 0.53 | 0.08 | -0.75 | -0.56 | -0.73 | -1.31 | -0.15 |
| EPS Diluted | -0.64 | 0.08 | 0.42 | -0.22 | 0.10 | -0.02 | -0.22 | -0.47 | -0.65 | -0.06 | 0.22 | 0.08 | 0.08 | -0.18 | -0.34 | 0.00 | 0.33 | 0.31 | 0.09 | 0.06 | 0.53 | 0.08 | -0.75 | -0.56 | -0.73 | -1.31 | -0.15 |
| Weighted Avg Shares Out | 30.38M | 30.36M | 29.14M | 28.64M | 21.86M | 21.19M | 20.80M | 20.35M | 20.15M | 19.90M | 19.58M | 19.44M | 19.18M | 18.72M | 18.24M | 18.07M | 18.16M | 18.01M | 17.47M | 17.36M | 17.53M | 16.47M | 9.41M | 9.24M | 9.13M | 3.74M | 2.67M |
| Weighted Avg Shares Out (Dil) | 30.38M | 31.32M | 30.23M | 28.64M | 22.11M | 21.19M | 20.93M | 20.41M | 20.30M | 19.90M | 19.97M | 19.70M | 19.42M | 18.72M | 18.24M | 18.07M | 18.66M | 18.96M | 18.01M | 17.78M | 17.91M | 16.48M | 9.41M | 9.24M | 9.13M | 3.74M | 2.67M |
Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq
RESEARCH TRIANGLE PARK, N.C. , Nov. 27, 2024 /PRNewswire/ -- Charles & Colvard, Ltd.
Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq
RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2024 /PRNewswire/ -- Charles & Colvard, Ltd.
Charles & Colvard, Ltd. Comments on a Letter from Riverstyx Capital Management to Charles & Colvard Shareholders
Notes that Purported Nomination of Director Candidates by a Riverstyx Principal Is Invalid and that the Nominations Will Not be Recognized RESEARCH TRIANGLE PARK, N.C. , Oct. 7, 2024 /PRNewswire/ -- Charles & Colvard, Ltd.
Zacks Initiates Coverage of Charles & Colvard With Underperform Recommendation
Discover why Zacks has rated Charles & Colvard as "Underperform," being the first on Wall Street to initiate coverage on the stock. Explore the significant challenges posed by declining sales, shrinking margins, rising expenses, fierce competition and liquidity concerns, despite...
CHARLES & COLVARD REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT
RESEARCH TRIANGLE PARK, N.C. , June 6, 2024 /PRNewswire/ -- Charles & Colvard, Ltd.
CHARLES & COLVARD FORGES EXCLUSIVE STRATEGIC ALLIANCE WITH IGI TO SUPPLY MOISSANITE GRADING REPORTS
RESEARCH TRIANGLE PARK, N.C., May 23, 2024 /PRNewswire/ -- Charles & Colvard, Ltd.
CHARLES & COLVARD ANNOUNCES REVERSE STOCK SPLIT
RESEARCH TRIANGLE PARK, N.C., May 15, 2024 /PRNewswire/ -- Charles & Colvard, Ltd.
Charles & Colvard, Ltd. (CTHR) Q3 2024 Earnings Call Transcript
Charles & Colvard, Ltd. (NASDAQ:CTHR ) Q3 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Don O'Connell - President & Chief Executive Officer Clint Pete - Chief Financial Officer Conference Call Participants Bruce Lindenman - Investor...
CHARLES & COLVARD REPORTS THIRD QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS
Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C. , May 2, 2024 /PRNewswire/ -- Charles & Colvard, Ltd.
CHARLES & COLVARD TO HOST THIRD QUARTER FISCAL YEAR 2024 INVESTOR CONFERENCE CALL ON MAY 2, 2024 AT 4:30 PM ET
RESEARCH TRIANGLE PARK, N.C. , April 23, 2024 /PRNewswire/ -- Charles & Colvard, Ltd.
Source: https://incomestatements.info
Category: Stock Reports